View in EDS

Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer.

Saved in:
Bibliographic Details
Title: Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer.
Authors: Zecca E; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Zambelli L; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Tinè G; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bracchi P; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Miceli R; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pigni A; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Lo Dico S; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Ricchini F; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Mariani G; Medical Oncology Department, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Massa G; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan Italy Department of Excellence 2023 - 2027, Italy. Electronic address: giacomo.massa@istitutotumori.mi.it., Caraceni A; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan Italy Department of Excellence 2023 - 2027, Italy.
Source: Breast (Edinburgh, Scotland) [Breast] 2025 Dec; Vol. 84, pp. 104596. Date of Electronic Publication: 2025 Oct 13.
Publication Type: Journal Article; Observational Study; Comparative Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3080
DOI:10.1016/j.breast.2025.104596